206 related articles for article (PubMed ID: 23327720)
1. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.
Incecayir T; Tsume Y; Amidon GL
Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720
[TBL] [Abstract][Full Text] [Related]
2. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa.
Zhang W; Liu H; Liu C
Biopharm Drug Dispos; 2019 Sep; 40(8):276-281. PubMed ID: 31294470
[TBL] [Abstract][Full Text] [Related]
4. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol.
Zur M; Gasparini M; Wolk O; Amidon GL; Dahan A
Mol Pharm; 2014 May; 11(5):1707-14. PubMed ID: 24735251
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein.
Incecayir T; Ilbasmis-Tamer S; Tirnaksiz F; Degim T
Pharmazie; 2016 Aug; 71(8):472-477. PubMed ID: 29442035
[TBL] [Abstract][Full Text] [Related]
6. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
7. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
8. Regional Intestinal Permeability in Rats: A Comparison of Methods.
Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H
Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690
[TBL] [Abstract][Full Text] [Related]
9. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
Dahan A; Amidon GL
Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
[TBL] [Abstract][Full Text] [Related]
10. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models.
Zhou W; Di LQ; Wang J; Shan JJ; Liu SJ; Ju WZ; Cai BC
Acta Pharmacol Sin; 2012 Aug; 33(8):1069-79. PubMed ID: 22773077
[TBL] [Abstract][Full Text] [Related]
13. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.
Dahan A; Miller JM; Hilfinger JM; Yamashita S; Yu LX; Lennernäs H; Amidon GL
Mol Pharm; 2010 Oct; 7(5):1827-34. PubMed ID: 20701326
[TBL] [Abstract][Full Text] [Related]
14. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
15. The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum.
Sandström R; Karlsson A; Lennernäs H
J Pharm Pharmacol; 1998 Jul; 50(7):729-35. PubMed ID: 9720621
[TBL] [Abstract][Full Text] [Related]
16. Regional Intestinal Permeability of Three Model Drugs in Human.
Dahlgren D; Roos C; Lundqvist A; Abrahamsson B; Tannergren C; Hellström PM; Sjögren E; Lennernäs H
Mol Pharm; 2016 Sep; 13(9):3013-21. PubMed ID: 27504798
[TBL] [Abstract][Full Text] [Related]
17. Concentration- and region-dependent intestinal permeability of fluvastatin in the rat.
Lindahl A; Sandström R; Ungell AL; Lennernäs H
J Pharm Pharmacol; 1998 Jul; 50(7):737-44. PubMed ID: 9720622
[TBL] [Abstract][Full Text] [Related]
18. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
[TBL] [Abstract][Full Text] [Related]
19. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.
Dahan A; West BT; Amidon GL
Eur J Pharm Sci; 2009 Feb; 36(2-3):320-9. PubMed ID: 19028572
[TBL] [Abstract][Full Text] [Related]
20. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
Zur M; Cohen N; Agbaria R; Dahan A
Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]